{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:52:21Z","timestamp":1789941141604,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"none","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12471-019-1253-2","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T13:04:20Z","timestamp":1553087060000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a\u00a06-year survey of 6,545 consecutive patients"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-7959","authenticated-orcid":false,"given":"R.","family":"Rozemeijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wing Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Z.","family":"Rittersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kraaijeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Voskuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a\u00a0large two-institutional cohort study. Lancet. 2007;369:667\u201378.","journal-title":"Lancet"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.105.600155","volume":"113","author":"PK Kuchulakanti","year":"2006","unstructured":"Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108\u201313.","journal-title":"Circulation"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document. Circulation. 2018;137:2635\u201350.","journal-title":"Circulation"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","volume":"82","author":"SG Ellis","year":"1990","unstructured":"Ellis SG, Vandormael MG, Cowley MJ, et\u00a0al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193\u2013202.","journal-title":"Circulation"},{"key":"1253_CR6","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, et\u00a0al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/S0140-6736(02)08594-X","volume":"359","author":"SJ Pocock","year":"2002","unstructured":"Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet. 2002;359:1686\u20139.","journal-title":"Lancet"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","volume":"6","author":"T Tada","year":"2013","unstructured":"Tada T, Byrne RA, Simunovic I, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a\u00a0registry of 18,334 patients. JACC Cardiovasc Interv. 2013;6:1267\u201374.","journal-title":"JACC Cardiovasc. Interv."},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","volume":"113","author":"JA Spertus","year":"2006","unstructured":"Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803\u20139.","journal-title":"Circulation"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","volume":"116","author":"F Airoldi","year":"2007","unstructured":"Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116:745\u201354.","journal-title":"Circulation"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW Werkum van","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, et\u00a0al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J\u00a0Am Coll Cardiol. 2009;53:1399\u2013409.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/CIRCULATIONAHA.110.938290","volume":"122","author":"I Ferreira-Gonzalez","year":"2010","unstructured":"Ferreira-Gonzalez I, Marsal JR, Ribera A, et al. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation. 2010;122:1017\u201325.","journal-title":"Circulation"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","volume":"382","author":"R Mehran","year":"2013","unstructured":"Mehran R, Baber U, Steg PG, et\u00a0al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a\u00a0prospective observational study. Lancet. 2013;382:1714\u201322.","journal-title":"Lancet"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2007.10.057","volume":"51","author":"JM Torre-Hernandez de la","year":"2008","unstructured":"de la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). J\u00a0Am Coll Cardiol. 2008;51:986\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.jacc.2008.01.070","volume":"51","author":"T Chechi","year":"2008","unstructured":"Chechi T, Vecchio S, Vittori G, et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis a\u00a0new group of high-risk patients. J\u00a0Am Coll Cardiol. 2008;51:2396\u2013402.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/eurheartj\/ehi135","volume":"26","author":"P Wenaweser","year":"2005","unstructured":"Wenaweser P, Rey C, Eberli FR, et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart\u00a0J. 2005;26:1180\u20137.","journal-title":"Eur Heart J"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.108.804203","volume":"119","author":"J Aoki","year":"2009","unstructured":"Aoki J, Lansky AJ, Mehran R, et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy Trial. Circulation. 2009;119:687\u201398.","journal-title":"Circulation"},{"key":"1253_CR18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jcin.2017.06.001","volume":"10","author":"R Piccolo","year":"2017","unstructured":"Piccolo R, Feres F, Abizaid A, et al. Risk of early adverse events after clopidogrel discontinuation in patients undergoing short-term dual antiplatelet therapy: an individual participant data analysis. JACC Cardiovasc Interv. 2017;10:1621\u201330.","journal-title":"JACC Cardiovasc. Interv."},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.108.808311","volume":"119","author":"T Kimura","year":"2009","unstructured":"Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987\u201395.","journal-title":"Circulation"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","volume":"388","author":"ZA Ali","year":"2016","unstructured":"Ali ZA, Maehara A, Genereux P, et\u00a0al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a\u00a0randomised controlled trial. Lancet. 2016;388:2618\u201328.","journal-title":"Lancet"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jcin.2009.07.006","volume":"2","author":"F Sera","year":"2009","unstructured":"Sera F, Awata M, Uematsu M, et al. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy. JACC Cardiovasc Interv. 2009;2:989\u201394.","journal-title":"JACC Cardiovasc. Interv."},{"key":"1253_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jcin.2011.07.005","volume":"4","author":"BE Claessen","year":"2011","unstructured":"Claessen BE, Mehran R, Mintz GS, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv. 2011;4:974\u201381.","journal-title":"JACC Cardiovasc. Interv."},{"key":"1253_CR23","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1001\/jama.2015.15454","volume":"314","author":"SJ Hong","year":"2015","unstructured":"Hong SJ, Kim BK, Shin DH, et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314:2155\u201363.","journal-title":"JAMA"},{"key":"1253_CR24","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1093\/eurheartj\/ehv367","volume":"36","author":"W Wijns","year":"2015","unstructured":"Wijns W, Shite J, Jones MR, et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study. Eur Heart\u00a0J. 2015;36:3346\u201355.","journal-title":"Eur Heart J"},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","volume":"37","author":"G Souteyrand","year":"2016","unstructured":"Souteyrand G, Amabile N, Mangin L, et\u00a0al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart\u00a0J. 2016;37:1208\u201316.","journal-title":"Eur Heart J"},{"key":"1253_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ahj.2014.11.012","volume":"169","author":"F Prati","year":"2015","unstructured":"Prati F, Kodama T, Romagnoli E, et al. Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a\u00a0multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study. Am Heart\u00a0J. 2015;169:249\u201356.","journal-title":"Am Heart J"},{"key":"1253_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","volume":"129","author":"B Witzenbichler","year":"2014","unstructured":"Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129:463\u201370.","journal-title":"Circulation"},{"key":"1253_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ccd.26409","volume":"89","author":"P Genereux","year":"2017","unstructured":"Genereux P, Redfors B, Witzenbichler B, et al. Angiographic predictors of 2\u2011year stent thrombosis in patients receiving drug-eluting stents: insights from the ADAPT-DES study. Catheter Cardiovasc Interv. 2017;89:26\u201335.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1253_CR29","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","volume":"306","author":"G Cayla","year":"2011","unstructured":"Cayla G, Hulot JS, O\u2019Connor SA, et\u00a0al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA. 2011;306:1765\u201374.","journal-title":"JAMA"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","volume":"68","author":"G Giustino","year":"2016","unstructured":"Giustino G, Chieffo A, Palmerini T, et\u00a0al. Efficacy and safety of dual antiplatelet therapy after complex PCI. J\u00a0Am Coll Cardiol. 2016;68:1851\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126\u201330.","journal-title":"JAMA"},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ahj.2009.12.032","volume":"159","author":"M Ergelen","year":"2010","unstructured":"Ergelen M, Gorgulu S, Uyarel H, et al. The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction. Am Heart\u00a0J. 2010;159:672\u20136.","journal-title":"Am Heart J"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-019-1253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-019-1253-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-019-1253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:27:54Z","timestamp":1584577674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-019-1253-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1007\/s12471-019-1253-2","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"20 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Rozemeijer, C.\u00a0Wing Wong, G.\u00a0Leenders, L.\u00a0Timmers, S.\u00a0Koudstaal, S.Z.\u00a0Rittersma, A.\u00a0Kraaijeveld, M.\u00a0Bots, P.\u00a0Doevendans, P.\u00a0Stella and M.\u00a0Voskuil declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}